Skip to main content

Table 2 Summary of the mercury in urine and plasma values at screening, day 15 and day 45

From: Efficacy of N,N‘bis-(2-mercaptoethyl) isophthalamide on mercury intoxication: a randomized controlled trial

 

NBMI 300 mg (n = 11)

NBMI 100 mg (n = 13)

Placebo (n = 12)

Mercury in urine [μg/l]a

  

 Screening

26.5 (4.22–321.0)

39.1 (12.6–160.0)

9.16 (1.7–230.0)

 Day 15

18.5 (2.1–131)

37.7 (8.1–132.0)

13.9 (1.3–161.0)

 Day 45

14.2 (1.8–226.0)

39.1 (2.6–96.1)

11.3 (1.3–275.0)

Mercury in urine [μg/g creatinine]a

  

 Screening

62.4 (7.6–773.2)

66.7 (12.4–200)

18.7 (2.6–488.5)

 Day 15

65.2 (2.6–298.0)

64.4 (17.2–241.0)

29.75 (1.8–536.7)

 Day 45

34.8 (2.9–1883.3)

53.3 (13.2–340.2)

9.86 (0.4–1797.4)

Mercury in plasma [μg/l]a

  

 Screening

5.8 (1.3–95.9)

6.4 (1.7–25.8)

6.1 (1.4–45.8)

 Day 15

6.8 (1.7–64.4)

8.0 (2.6–33.6)

5.1 (1.5–42.9)

 Day 45

6.4 (1.8–49.0)

9.3 (1.6–42.2)

5.9 (1.0–90.1)

  1. aShown values are medians. Range is shown in brackets